Skip to main content
. 2021 Jul 19;10(7):e1312. doi: 10.1002/cti2.1312

Figure 2.

Figure 2

Evaluation of antibody development after symptom onset or a positive PCR test in a total of 301 individuals, shown as number of seronegative post‐infection samples per antigen and day. The red dashed line indicates the selected cut‐off for the definition of a positive control.